Craft

EnteroBiotix

Total Funding

$3.2 M

EnteroBiotix Summary

Company Summary

Overview
EnteroBiotix is a biopharmaceutical company that develops a microbiome therapeutics platform. It utilizes gut microbiome to develop novel medicinal products that restore health and prevent disease, focusing on drug-resistant bacterial infections and gastrointestinal conditions.
Type
Private
Status
Active
Founded
2017
HQ
Bellshill, GB | view all locations
Website
https://enterobiotix.com
Cybersecurity rating
Sectors

Key People

  • James R. McIlroy

    James R. McIlroy, Founder, Chief Executive Officer, and Director

  • Kimberley McAleney

    Kimberley McAleney, Director of People & Culture

  • Douglas Thomson

    Douglas Thomson, Investor Director

  • Chris Lea

    Chris Lea, Chief Financial Officer and Company Secretary

LocationsView all

3 locations detected

  • Bellshill, Scotland HQ

    United Kingdom

    Phoenix House, Phoenix Crescent Strathclyde Business Park

  • Aberdeen, Scotland

    United Kingdom

    Aberdeen Blood Donor Centre, Foresterhill Health Campus Foresterhill

  • Glasgow, Scotland

    United Kingdom

    1 West Regent Street

EnteroBiotix Financials

Summary Financials

Net income (FY, 2022)
(£4.3M)
Cash (Y, 2022)
£8.7M

Footer menu